Delivery Order 75N95024D00009-75N95025F00001
Award Date
5/13/25
Potential Completion Date
3/31/27
Potential Value
$26K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Bachem Americas Inc.
Ultimate Awardee
Not listed
NAICS Category
325411 - Medicinal and Botanical Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Torrance, CA 90505, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The National Institutes of Health National Center for Advancing Translational Sciences awarded Bachem Americas, Inc. a $597,350 firm fixed price delivery order contract under the prime vendor's master indefinite-delivery/indefinite-quantity contract for Clinical Research Organization Support. The order is for Bachem Americas, Inc. to manufacture 150 grams of cGMP Parathyroid Hormone-related Protein type 1A in support of the funding agency's drug substance development and manufacture programs....
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services, to Bachem Americas, Inc. for the custom synthesis of 20 mg peptides with >95% purity, including quality control analytical services. The contract ceiling value is $4,315.00 and the ultimate completion date is March 26, 2016. Bachem Americas, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical ingredients...
This is a $447,635.80 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. government. The contract is for the "SMALL MOLECULES FOR NCATS PHARMACOLOGICALLY ACTIVE CHEMICAL TOOLBOX (NPACT)" program and was awarded to Analyticon Discovery, LLC, a for-profit foreign-owned organization. The contract does not have a set-aside designation and has an ultimate completion date of January 31, 2016. NCATS is...
<p>The U.S. Centers for Disease Control and Prevention (CDC) awarded a $28,542.50 firm fixed-price purchase order to Gold Biotechnology Inc. for the acquisition of PTH(7-84). The contract has an ultimate completion date of September 30, 2024 and was awarded on August 21, 2024. The place of performance is Chamblee, Georgia. This contract award was not set aside for any specific business type.</p>
This is a federal contract awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency, to Compound Focus Inc. for the operation and maintenance of the NCATS Small Molecule Repository. The contract has a ceiling value of $2,093,753.88 and was awarded on June 14, 2016, with a period of performance through June 13, 2017. The contract is a Delivery Order with a Cost Plus Fixed Fee pricing type, and there is no set-aside designation. The contract is not...
This is a $90,075 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences (NCATS), a component of the U.S. Department of Health and Human Services, to American Biochemicals Inc. The contract is for the synthesis of approximately 50 analogs of the small molecule compound metarrestin, which is being developed as an anti-metastasis agent for pancreatic cancer. The goal is to reduce the brain exposure of the compounds while maintaining their...
<p>This federal contract award was issued by the National Center for Advancing Translational Sciences, a civilian agency, to AAT Bioquest, Inc. The contract has a ceiling value of $12,570.00 and is a Firm Fixed Price Purchase Order with an ultimate completion date of August 31, 2018. The contract does not have a set-aside designation. Based on the agency and description, this contract is likely related to the agency's research and development efforts in the field of translational sciences.</p>
This federal contract award, valued at $87,024.00, was issued by the U.S. Food and Drug Administration (FDA) to Bachem Americas, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical ingredients. The award is a purchase order contract with a firm fixed price for the delivery of FDA DROPSHIP products. There is no set-aside designation for this contract. Bachem Americas, Inc. appears to act as the prime contractor without any major subcontractors listed. The company has previously...
<p>This is a $92,334.95 firm fixed price purchase order contract awarded by the National Center for Advancing Translational Sciences, a civilian agency, to Apexbio Technology, LLC, a small business, for the delivery of 2,234 compounds of 5mg size. The contract has a completion date of July 20, 2015. This contract award is not associated with a larger contract vehicle.</p>
This is a Cost Plus Fixed Fee delivery order contract awarded by the National Center for Advancing Translational Sciences (NCATS), which is part of the National Institutes of Health (NIH), a civilian federal agency. The contract, with a ceiling value of $2,391,161.12, is for the procurement of new equipment for the NIH Small Molecule Repository program. The prime contractor is Compound Focus Inc., and the place of performance is South San Francisco, California. The contract does not have a...